These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19519381)

  • 41. Selected fundamental aspects of chiral electromigration techniques and their application to pharmaceutical and biomedical analysis.
    Scriba GK
    J Pharm Biomed Anal; 2002 Jan; 27(3-4):373-99. PubMed ID: 11755740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analogues of Anticancer Natural Products: Chiral Aspects.
    Valentová J; Lintnerová L; Miklášová N; Oboňová B; Habala L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
    Patel RN
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective.
    Afouna MI; Fincher TK; Khan MA; Reddy IK
    Chirality; 2003 May; 15(5):456-65. PubMed ID: 12692892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereochemical aspects of pharmacotherapy.
    Brocks DR; Jamali F
    Pharmacotherapy; 1995; 15(5):551-64. PubMed ID: 8570426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homochiral drug design and development by racemization.
    Ali I
    Comb Chem High Throughput Screen; 2007 Jun; 10(5):326-35. PubMed ID: 17896928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances in SPE-chiral-HPLC methods for enantiomeric separation of chiral drugs in biological samples.
    Ali I; Alam SD; Al-Othman ZA; Farooqi JA
    J Chromatogr Sci; 2013 Aug; 51(7):645-54. PubMed ID: 23377648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The chromatographic separation of enantiomers through nanoscale design.
    Sancho R; Minguillón C
    Chem Soc Rev; 2009 Mar; 38(3):797-805. PubMed ID: 19322471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of racemisation of the enantiomers of glitazone drug compounds at different pH using chiral HPLC and chiral CE.
    Jamali B; Bjørnsdottir I; Nordfang O; Hansen SH
    J Pharm Biomed Anal; 2008 Jan; 46(1):82-7. PubMed ID: 17942259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs.
    Jacques V; Czarnik AW; Judge TM; Van der Ploeg LH; DeWitt SH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1471-9. PubMed ID: 25775521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
    Rantanen J; Khinast J
    Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
    [No Abstract]   [Full Text] [Related]  

  • 53. Stereoselectivity in drug metabolism.
    Lu H
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three-dimensional pharmacology, a subject ranging from ignorance to overstatements.
    Waldeck B
    Pharmacol Toxicol; 2003 Nov; 93(5):203-10. PubMed ID: 14629731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asymmetry on large scale: the roadmap to stereoselective processes.
    Federsel HJ
    Nat Rev Drug Discov; 2005 Aug; 4(8):685-97. PubMed ID: 16041317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.
    Fortuna A; Alves G; Falcão A
    Biomed Chromatogr; 2014 Jan; 28(1):27-58. PubMed ID: 23946142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Chirality in Drugs: An Overview.
    Alkadi H; Jbeily R
    Infect Disord Drug Targets; 2018; 18(2):88-95. PubMed ID: 28356054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding chirality and stereochemistry: three-dimensional psychopharmacology.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2009 Jul; 47(7):15-8. PubMed ID: 19678474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Searching for scalable processes: addressing the challenges in times of increasing complexity.
    Federsel HJ
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):838-47. PubMed ID: 14758755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.